Top Story

FDA approves optical imaging agent to assist in resection of high-grade glioma

June 22, 2017

The FDA approved aminolevulinic acid hydrochloride as an optical imaging agent indicated for patients with gliomas as an adjunct for the visualization of malignant tissue during surgery, according to the agent’s manufacturer.

Patients take the oral compound 3 hours before undergoing surgery, so the drug reaches the brain tumor and is metabolized into a fluorescent form to enable fluorescence-guided surgery, according to Costas Hadjipanayis, MD, PhD, chair of the department of neurosurgery at Mount Sinai Beth Israel and director of neurosurgical oncology for the Mount Sinai Health System.

SynergEyes adds new leadership

June 22, 2017
Louise Sclafani, OD, FAAO, is joining SynergEyes as the vice president of professional affairs, according to a company press release. In this position Sclafani will be…
In the Journals

Extensive preop chemo for colorectal liver metastases linked to hepatic atrophy

June 22, 2017
Results of a recently published study showed an association between extensive preoperative chemotherapy in patients with colorectal liver metastases and hepatic atrophy…
In the Journals

Head position may not affect outcomes during acute stroke treatment

June 22, 2017
During treatment for acute stroke, whether a patient was lying down or sitting up did not make a difference in disability outcomes, according to a study in The New
Meeting News

SomnaPatch possible tool to detect sleep apnea

June 22, 2017
SomnaPatch, a new skin-adhesive diagnostic patch, provided significant clinical value for the detection of sleep apnea across all severity levels, compared with standard…
More News Headlines »
CME CNE CPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »
Feature Article

Pain and Opioid Use After Total Shoulder Arthroplasty With Injectable Liposomal Bupivacaine Versus Interscalene Block

Orthopedics
Online Advanced Release, June 15, 2017
Postoperative pain control is a significant concern after total shoulder arthroplasty. Injectable periarticular…
More »
Featured
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Video
Meeting News

VIDEO: Immunotherapy agent induces response in prostate cancer

June 20, 2017
More »
Advertisement
Advertisement